European Medicines Agency workshop on medicines for older people

• Date:
  Thursday, 22 March 2012, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency is hosting a two-day workshop on medicines for older people. Although speakers will be by invitation and capacity will be limited, the Agency is inviting interested experts andstakeholders to send an expression of interest to attend this workshop by 9 December 2011 to [e-mail].

Documents

European Medicines Agency workshop on medicines for older people - Invitation for expressions of interest

Reference Number: EMA/826786/2011 Summary:

The European Medicines Agency (EMA) announces a two-day workshop on medicines for older people. The workshop will be held at the EMA, in London, UK. The provisional dates foreseen for the workshop are 22-23 March 2012.

Agenda - Fourth stakeholder forum on the implementation of the new 2010 pharmacovigilance legislation

Reference Number: EMA/53186/2012

Presentation - European Medicines Agency geriatric medicines strategy

Presentation - Healthy ageing and medicines: the patients' perspective of ageing

Presentation - The industry's views on geriatric medicines

Presentation - International Conference of Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use E7 requirements and how they are translated in practice

Presentation - Elderly patients and clinical trials: European Medicines Agency notes for guidance

Presentation - Can pharmacokinetics and modelling help?

Presentation - Modelling and simulation to support evaluation of safety and efficacy of drugs in older patients

Presentation - How to get better data on medicines post-licensing

Presentation - Endpoints and their relevance to older people: cancer and palliative care and the work of the European Organization for Research and Treatment of Cancer

Presentation - Endpoints and indications for the older population

Presentation - Frailty: Challenges and possible solutions

Presentation - The cluster medicine approach

Presentation - The industry's views on 'older' old patients

Presentation - Increasing enrolment in clinical trials and the Increasing the Participation of the Elderly In Clinical Trials (PREDICT) study

Presentation - Efficacy and effectiveness models

Presentation - Proposal for guidance on medical research for and with older people in Europe

Presentation - Practical proposals on recruitment improvement: Research and development approach and focus on possible bottleneck issues

Presentation - Medication errors and screening tool of older persons’ potentially inappropriate prescriptions (STOPP) / screening tool to alert doctors to right treatment (START) criteria

Presentation - Predictors of outcome and renal clearance

Presentation - Pharmacovigilance and the elderly: Some proposals for improvement

Presentation - EudraVigilance and signal detection

Presentation - Industry perspective

Presentation - Pharmacovigilance in the elderly: Conclusions

Presentation - Formulations, packaging and medication practice considerations

Presentation - Industry perspective on formulation and packaging considerations

Presentation - What do we need to consider to ensure medication adherence of older adults?

Presentation - Providing information to the older population: Understanding the needs of older people

Presentation - A national-competent-authority analysis of approval documents

Presentation - How can summary-of-product-characteristics and European-public-assessment-report information contribute to the safe and effective use of medicines in the older population?

Presentation - Package leaflet initiatives

Presentation - Providing information to the older population: An industry perspective

Presentation - Conclusions

Ensuring safe and effective medicines for an ageing population: Workshop proceedings

Reference Number: EMA/425943/2012

Multimedia